KLSE (MYR): YSPSAH (7178)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.90
Today's Change
-0.03 (1.02%)
Day's Change
2.88 - 2.95
Trading Volume
64,700
Market Cap
411 Million
NOSH
142 Million
Latest Quarter
31-Mar-2024 [#1]
Announcement Date
21-May-2024
Next Quarter
30-Jun-2024
Est. Ann. Date
22-Aug-2024
Est. Ann. Due Date
29-Aug-2024
QoQ | YoY
69.84% | 27.90%
Revenue | NP to SH
368,035.000 | 40,332.000
RPS | P/RPS
259.46 Cent | 1.12
EPS | P/E | EY
28.43 Cent | 10.20 | 9.80%
DPS | DY | Payout %
10.00 Cent | 3.45% | 35.04%
NAPS | P/NAPS
2.88 | 1.01
QoQ | YoY
8.09% | 4.04%
NP Margin | ROE
11.12% | 9.87%
F.Y. | Ann. Date
31-Mar-2024 | 21-May-2024
Latest Audited Result
31-Dec-2023
Announcement Date
23-Apr-2024
Next Audited Result
31-Dec-2024
Est. Ann. Date
23-Apr-2025
Est. Ann. Due Date
29-Jun-2025
Revenue | NP to SH
354,995.000 | 37,315.000
RPS | P/RPS
250.27 Cent | 1.16
EPS | P/E | EY
26.31 Cent | 11.02 | 9.07%
DPS | DY | Payout %
10.00 Cent | 3.45% | 38.01%
NAPS | P/NAPS
2.79 | 1.04
YoY
8.27%
NP Margin | ROE
10.66% | 9.43%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Revenue | NP to SH
434,512.000 | 55,328.000
RPS | P/RPS
306.33 Cent | 0.95
EPS | P/E | EY
39.00 Cent | 7.43 | 13.45%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
48.27% | 27.9%
NP Margin | ROE
13.09% | 13.54%
F.Y. | Ann. Date
31-Mar-2024 | 21-May-2024
Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
gamblers ? i thought most of us will forget we owned this stock until we received a cheque notice about the dividend . hahaha
2021-09-01 16:19
As i mentioned, hold long term for good profit
Refered to my message on 30/8/21
2021-09-01 16:59
Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.
2021-09-22 11:31
Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???
2022-04-02 21:53
Buy-side has no more idea. They will pump all the healthcare stocks remaining
2022-11-04 11:22
walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy
2022-12-13 12:48
Finally this share has released it's true potential power. I have been waiting years for it to shine
2023-01-03 19:55
Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023
2023-02-23 16:34
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3
2023-03-30 17:12
New Production line is started to be operated for the newly acquired factory premise. With the newly operated production line, the company's Revenue YoY % growth will be significantly increased within 2 years.
1 month ago
Hi BullishMarket, from where you aware that New Production line is started to be operated for the newly acquired factory premise?
1 month ago
bought a few at 2.85, acceptable bargain I think considering today open at RM3
1 month ago
https://www.facebook.com/xngyuan/videos/828026755888524?idorvanity=3251240861803724
chenjian sifu commented YSPSAH positively
1 month ago
reasons to buy:
1. recorded highest revenue and profit in 20years
2. organic growth, hold patents (expect to continue deliver good result)
3. DY 3.5% above RM0.11 ex 24/6/24
let's monitor
😎
1 month ago
Yspsah has been all the while being the lowest valuation company against its peers like Ahealth & Dpharma.
1 month ago
https://www.ctee.com.tw/news/20220714700772-439801
永信東南亞控股是台灣本土學名藥製藥廠中,第一家跨國上市的公司。這兩年,受疫情影響,年營收成長仍有3%〜5%。即將來臨的後疫情時代,李芳信預計,自2022年起,公司營收至少有雙位數以上的成長。
3 days ago
Lightofheaven
Hold for long term
The profit is promising
2021-08-30 13:55